These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38814916)

  • 1. The efficacy of Topical Clascoterone versus systematic spironolactone for treatment of acne vulgaris: A systematic review and network meta-analysis.
    Basendwh MA; Alharbi AA; Bukhamsin SA; Abdulwahab RA; Alaboud SA
    PLoS One; 2024; 19(5):e0298155. PubMed ID: 38814916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years.
    Piszczatoski CR; Powell J
    Clin Ther; 2021 Oct; 43(10):1638-1644. PubMed ID: 34607697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Alkhodaidi ST; Al Hawsawi KA; Alkhudaidi IT; Magzoub D; Abu-Zaid A
    Dermatol Ther; 2021 Jan; 34(1):e14609. PubMed ID: 33258536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Clascoterone for Acne Vulgaris.
    Burma NE; Woo TE; Parsons L
    Skin Therapy Lett; 2022 Jan; 27(1):1-3. PubMed ID: 35081302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
    Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A
    JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris.
    Eichenfield LF; Gold LS; Han J; Hebert AA; Mazzetti A; Moro L; Squittieri N; Thiboutot D
    J Drugs Dermatol; 2024 Jan; 23(1):1278-1283. PubMed ID: 38206145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne.
    Kalabalik-Hoganson J; Frey KM; Ozdener-Poyraz AE; Slugocki M
    Ann Pharmacother; 2021 Oct; 55(10):1290-1296. PubMed ID: 33533262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist.
    Kircik LH
    Expert Opin Pharmacother; 2021 Sep; 22(13):1801-1806. PubMed ID: 33906537
    [No Abstract]   [Full Text] [Related]  

  • 11. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older.
    Gold M
    Expert Rev Clin Immunol; 2021 Apr; 17(4):301-308. PubMed ID: 33616473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials-Does this therapy open a path towards favorable outcomes?
    Rehan ST; Khan Z; Abbas S; Imran L; Munir S; Tahir MJ; Kheljee AZ; Eljack MMF; Ahmed A
    J Dermatol; 2023 Feb; 50(2):166-174. PubMed ID: 36412248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.
    Mavranezouli I; Daly CH; Welton NJ; Deshpande S; Berg L; Bromham N; Arnold S; Phillippo DM; Wilcock J; Xu J; Ravenscroft JC; Wood D; Rafiq M; Fou L; Dworzynski K; Healy E
    Br J Dermatol; 2022 Nov; 187(5):639-649. PubMed ID: 35789996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne.
    Peterson H; Kircik L; Armstrong AW
    J Drugs Dermatol; 2023 Jun; 22(6):SF350992s7-SF350992s14. PubMed ID: 37276168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.
    Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clascoterone: a new topical anti-androgen for acne management.
    Santhosh P; George M
    Int J Dermatol; 2021 Dec; 60(12):1561-1565. PubMed ID: 34242398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clascoterone: First Approval.
    Dhillon S
    Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clascoterone cream (Winlevi) for acne.
    Med Lett Drugs Ther; 2021 Dec; 63(1640):202-204. PubMed ID: 35100239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.